|Bid||0.00 x 3200|
|Ask||0.00 x 900|
|Day's Range||67.58 - 67.89|
|52 Week Range||61.28 - 77.91|
|PE Ratio (TTM)||27.09|
|Earnings Date||Oct 26, 2018|
|Forward Dividend & Yield||1.68 (2.49%)|
|1y Target Est||69.21|
As of August 15, shares of Kimberly-Clark (KMB) have risen 10.5% since its second-quarter results on July 24. The primary reason for the recovery in the stock price is the anticipated increase in net selling prices. Kimberly-Clark’s management stated during the second-quarter conference call that it plans to increase pricing to offset the pressure on margins from continued inflation in commodity prices, including pulp.
A majority of analysts providing recommendations for Church & Dwight (CHD) stock have a “neutral” outlook, despite the company’s stellar financial performance in the first half of the year and its upbeat sales and earnings outlook. Church & Dwight stock was trading at a forward PE multiple of 23.8x, which is higher than most of its peers. Church & Dwight stock is also trading at a premium to the S&P 500 Index (SPY).
Church & Dwight’s (CHD) bottom line is growing at a rapid rate. In the first quarter of 2018, its adjusted earnings marked a 21.2% increase. Its second-quarter EPS grew 19.5%. Its strong sales and a significant decline in the tax rate have been driving its earnings higher.
Church & Dwight (CHD) registered impressive sales growth in the past several quarters. The company’s top line has grown at a double-digit rate in the past four quarters, reflecting strong organic volumes and benefits from acquisitions. However, similar to its peers, pricing remained low and adversely impacted the top-line growth rate.
Most of the analysts continue to have a neutral outlook on the stocks of packaged goods manufacturers including Kimberly-Clark (KMB), Procter & Gamble (PG), Clorox (CLX), and Colgate-Palmolive (CL).
Clorox is one of only a few CPG companies that have managed to improve volumes as well as pricing. Other major CPG stocks like Procter & Gamble (PG), Kimberly-Clark (KMB), and Colgate-Palmolive (CL) have failed to improve pricing due to the heightened competitive environment. During the fiscal fourth quarter 2018 conference call, Clorox’s management stated that the company is increasing pricing in about 50% of its portfolio, which is expected to offset the negative impact from higher commodity costs.
Will These H1 2018 Stragglers Bounce Back in H2? Colgate-Palmolive’s (CL) first-half performance has been disheartening. Peers are no better, which is why Kimberly-Clark (KMB), Clorox (CLX), and Procter & Gamble (PG) are also trading in the red.
Lower net selling prices, lower birth rates in South Korea, and macroeconomic challenges in Latin America subdued volumes and pricing. Also, weakness in the United States and competitive challenges in China further pressured the sales growth rate. The company’s second-half sales performance isn’t likely to be different as persisting headwinds could continue to hurt the top-line growth rate.
Procter & Gamble (PG) managed to improve its net and organic sales growth rate in fiscal 2018 thanks to the favorable currency rates and higher volumes. Price investments to defend its market share in the grooming category and increased competition in the value segment restricted organic sales growth, which grew by only 1.0% in fiscal 2018. In the near term, pricing is expected to remain low and could adversely impact the organic sales growth rate.
Slow-moving consumer stocks aren't the sexiest investments, but those that can be relied on for regular dividend growth through both good times and bad can be a long-term investor's best friend. After all, bull markets and economic expansions don't last forever. "Quality dividend payers can also offer defensive, resilient businesses and current income generation to buffer against potential future (stock market) drawdowns," writes Tony DeSpirito, director of U.S. equity investments at BlackRock. Whether they make liquor, sell toothpaste or sling hamburgers, some of the nation's best-known consumer companies have proven to be dividend champions. Indeed, more than a dozen of them are members of the illustrious Dividend Aristocrats - companies in the Standard & Poor's 500-stock index that have hiked their payouts every year for at least 25 consecutive years. And let's not forget: Steady dividend hikes have benefits beyond letting income investors sleep better at night. Not only do annual raises make a dividend stock more alluring to new investors, they also reward existing investors with increasingly higher yields on shares purchased at lower prices in the past. These 15 quality consumer stocks can be counted on to deliver dividend growth year after year, and they are backed by resilient businesses to boot. SEE ALSO: 53 Best Dividend Stocks for 2018 and Beyond
In what’s come to seem like a ritual, the New Museum once again fixes its sights on art’s contradictory relationship to machines. Previous shows at the New York gallery have explored the mix of dread and ...
Consumer-products companies figure prominently near the top of the Management Top 250 ranking, including three companies that showed strength in every facet of management effectiveness that was analyzed.
NEW YORK, Aug. 09, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ING ...
Several analysts raised their target price on Clorox (CLX) stock following the company’s fourth fiscal quarter results. Wells Fargo increased its target price to $135 per share from $123. Meanwhile, Jefferies increased its target price on Clorox to $138 per share from $124. RBC raised its target price to $134 from $130.
Clorox (CLX) reported net sales of $1.7 billion, which fell short of analysts’ expectation. However, the net sales increased 2.7% YoY (year-over-year), which reflects benefits from its Nutranext acquisition, improved volumes, and higher pricing. The devaluation of the Argentine peso, the divestiture of the Aplicare business, and an unfavorable mix remained a drag.
On August 2, Clorox (CLX) reported mixed fourth fiscal quarter results for the period ending June 30. The company exceeded analysts’ EPS expectation for the quarter. Although Clorox’s sales fell short, its better gross margin outlook was impressive.
Procter & Gamble (PG) impressed with its bottom line performance in the fiscal fourth quarter. Its improved volumes and growth in key markets were positives. The company’s premium products are gaining traction, while innovation is supporting its volume growth. However, heightened competition in the Grooming and Baby Care segments continued to hurt the company’s overall sales growth rate.
Church & Dwight (CHD) reported its second-quarter results today, posting stellar sales and EPS growth and exceeding analysts’ estimates. A key highlight of its second quarter was its impressive organic sales growth.
Procter & Gamble (PG) reported better-than-expected bottom line results in its fiscal fourth quarter, which ended on June 30. The company managed to impress with its bottom line performance despite facing severe headwinds, including inflation in commodities, lower net pricing, and higher shipping costs.
Clorox (CLX) reported mixed fiscal fourth-quarter results today. The company’s bottom line came in ahead of analysts’ expectations, but revenues fell short of estimates. However, the key thing for investors to note is the company’s improved outlook on gross margins. Clorox’s management expects gross margins to stay flat or increase modestly in fiscal 2019, which is a positive. Clorox’s gross margin fell 100 basis points in fiscal 2018 due to higher commodity and shipping costs.
Procter & Gamble (PG) continues to struggle on the margin front as commodity inflation, higher shipment costs, and brand investments take a toll on its profitability. The company’s peers are no better, with Kimberly-Clark (KMB), Colgate-Palmolive (CL), and the Clorox Company (CLX) also having witnessed sluggish margins over the past several quarters.
Procter & Gamble (PG) reported net sales of $16.5 billion in the fiscal fourth quarter, up 2.6% YoY (year-over-year). However, as highlighted in our earlier series on Procter & Gamble, the company’s top line growth rate decelerated sequentially, reflecting lower pricing.